Journal article icon

Journal article

Acceptability of lopinavir/r pellets (minitabs), tablets and syrups in HIV-infected children

Abstract:

Background: Lopinavir/ritonavir ‘pellets’ were recently tentatively approved for licensing. We describe their acceptability for infants and children up to 48 weeks.
Methods: CHAPAS-2 was a randomised, 2-period crossover trial comparing syrup and pellets in HIV-infected infants (n=19, group A, aged 3-<12 months) and children (n=26, group B, 1-<4yrs) and tablets and pellets in older children (n=32, group C, 4-<13yrs) from 2 clinics (“JCRC”, “PIDC”) in Uganda. At week 8, all group...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Accepted manuscript

Actions


Access Document


Files:
Publisher copy:
10.3851/IMP3054

Authors


Kekitiinwa, A More by this author
Musiime, V More by this author
Thomason, MJ More by this author
Mirembe, G More by this author
Lallement, M More by this author
Expand authors...
Monument Trust More from this funder
Drugs for Neglected Diseases initiative More from this funder
Publisher:
International Medical Press Publisher's website
Journal:
Antiviral Therapy Journal website
Publication date:
2016-04-29
DOI:
ISSN:
1359-6535
URN:
uuid:0f00fc5e-5646-48de-9d40-4eae4bec360f
Source identifiers:
611142
Local pid:
pubs:611142

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP